LauraL.MulloyDOFACP,FASN,FAST

PubMed

• Reducing Disparities in Access to Kidney Transplantation (RaDIANT) Regional Study: A Randomized Trial in the Southeastern U.S.
  Rachel E Patzer, Jade Buford, Megan Urbanski, Laura McPherson, Sudeshna Paul
  Clinical Journal of the American Society of Nephrology. 2024-12-13
• New onset diabetic ketoacidosis in a renal transplant recipient.
  Havird McLean Skalak, Kaitlyn Haas, Melissa Laub, Laura L Mulloy
  The American Journal of the Medical Sciences. 2024-08-29
• 10 citations
  Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation System.
  Rachel E Patzer, Mengyu Di, Rebecca Zhang, Laura McPherson, Derek A DuBay
  American Journal of Kidney Diseases. 2022-12-01

Journal Articles

• 12-month outcome of the double-blind, randomized multicenter rejection trial of thymoglobulin vs Atgam in renal transplants.  
  Woodle ES, First MR, Gaber AO, Gaston RS, Mendez R, Mulloy LL, Kano JM, Schroeder TJ, Graft 2(1): 24-27
• AceI-Induced Attenuation of Platelet Timp-1 Production in Renal Allograph Recipients. Possible Impact on Erythropoiesis.  
  Lightfoot BO, Mulloy LL, Jagadeesan M, Ahmed S and Balachandran S, Transplantation Proceedings 34(5): 1806-1807
• Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications.  
  Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro, JT, Clinical Transplantation 15 (5), 330-336
• Randomized trial of prograf + mycophenolate mofetil or azathioprine vs neoral + mycophenolate mofetil after cadaveric kidney transplantation: Results at two years.  
  Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C III, Rocher S, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wach..., Transplantation 72:245-250
• Renal transplant patient compliance with free immunosuppressive medications.  
  Chisholm M, Vollenweider L, Mulloy L, Jagadeesan M, Wynn J, Wade W, DiPiro J, Transplantation 70:1240-1244
• Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic.  
  Chisholm M, Vollenweider L, Mulloy L, Wynn J, Wade B, DiPiro J, Transplantation 14:304-307
• Randomized trial of tacrolimus in combination with azathioprine or mycophenolate mofetil versus cyclosporine with mycophenolate mofetil after cadaveric kidney transpla...  
  Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C III, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Crowin C, Danovitch G, Wach..., Transplantation 69:834-841
• Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with myconphenolate mof...  
  Lawen JG, Davies EA, Mourad G, Oppeneheimer F, Molina MG, Rostaing L, Wilkinson AH, Mulloy LL, Bourbigot BJ, Prestele H, Korn A, Girault D, renal transplantation. 75 (1): 37-43
• Population pharmacokinetics and exposure-response relationships for basiliximab in renal transplantation.  
  Kovarik JM, Kahan BD, Rajagopalan PR, Bennett W, Mulloy LL, Gerbeau C, Hall ML, Transplantation 68(9): 1288-1294
• Multicenter Thymoglobulin Study Group. Correlation of histology in clinical rejection reversal: A. Thymoglobulin Multicenter Trial report.  
  Gaber LW, Moore LW, Gaber AO, Tesi RJ, Meyer J, Schroeder TJ for the U. S, Kidney International 55:2415-2422
• Simulect (Basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.  
  Mulloy LL, Wright F, Hall ML, Moore M, Transplantation Proceedings 31:1210-1213
• Conversion from Cyclosporine to Tacrolimus in Patients at Risk for Chronic Renal Alograft Failure: 60-Month Results of the CRAF Study.  
  Shihab FS, Waid T, Conti D, Yang H, Holman M, Mulloy L, Henning A, Holman Jr J, First MR, Transplantation, 85 (9): 1261-1269
• Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukine-2-receptor monoclonal a...  
  Kahan BD, Rajagopalan PR, Hall M, Transplantation 67:276-284
• Effects of Tacrolimus on hyperlipidemia after successful renal transplantation.  
  McCune TR, Thacker LR, Peters TG, Mulloy L, Rohr MS, Adams PA, Yium J, Light JA, Pruett T, Gaber AO, Selman SH, Jonsson J, Hayes JM, Wright FH, Armata T, Blanton J, Bu..., Transplantation 65:87-92
• Results of the double-blind, randomized, Multicenter, Phase III clinical trial of thymoglobulin versus ATGAM in the treatment of acute graft rejection episodes after r...  
  Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, et al, Transplantation 66:29-37
• Living-related kidney donation.  
  Wynn JJ, Barnett JE, Mulloy LL, Jagadeesan M, and Humphries AL, The Journal of the Medical Association of Georgia 87:80-82
• Cyclosporine, but not FK506, selectively induces renal and coronary artery smooth muscle contraction.  
  Epstein A, A Beall, J Wynn, L Mulloy and CM Brophy, Surgery 123:456-460
• Hypercalcemia due to hard water during home hemodialysis.  
  Mulloy, A.L., L.L. Mulloy and R.S. Weinstein, South. Med. J. 85:1131-1133
• Polymicrobial bacteremia in chronic hemodialysis patients.  
  Mulloy, L.L., R.J. Caruana, J.C.H. Steele and J. J. Wynn, Southern Medical Journal
• Isolation of Salmonella from laboratory-housed iguanid lizards.  
  Burdick, J.R., L.K. Lyngby and R.S. Tarr, J. of Herpetal. (18) pp. 88-91
• Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at ...  
  Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovi..., Transplantation 75 (12): 2048-53
• Development and validation of the immunosuppressant therapy adherence instrument (ITAS).  
  Chisholm MA, Lance CE, Williamson GM, Mulloy LL, Patient Education and Counseling. 59 (1): 13-20
• Join now to see all

Books/Book Chapters

• Introduction to Clinical Medicine. 
  Chapter: Renal Transplantation 
  Mulloy LL & Bowen PAEditors: Greene HL, Fincher RME, Johnson WP, Mandel R, Harrison G.Mosby Publishing CompanyEdition 2nd,
• Pharmacotherapy Casebook: A Patient-Focused Approach. 
  Chapter: Renal Transplantation 
  Chisholm MA, Bagby TR & Mulloy LLEditors: Schwinghammer Terry L.Appleton & Lange PublishersEdition 2nd,
• Dialysis Therapy. 
  Chapter: Isolated Ultrafiltration 
  Mulloy LL, Caruana RJ, Kozeny GA, Ing TEditors: Nissenson, Allen R., Fine, Richard N.Hanley & Belfus, IncEdition 3rd,
• Pharmacotherapy Casebook: a patient focused approach. 
  Chapter: Renal Transplantation 
  Chisholm MA and Mulloy LLEditors: Schwinghammer, Terry L. and DiPiro, Joseph T.The McGraw-Hill CompaniesEdition 3rd,
• Instructor’s Guide, Pharmacotherapy Casebook: a patient focused approach. 
  Chapter: Renal Transplantation 
  Chisholm MA and Mulloy LLEditors: Schwinghammer, Terry L.The McGraw-Hill CompaniesEdition 3rd,
• Hypertension in the Elderly. 
  Chapter: Combination drug therapy in the elderly 
  Prisant LM, and Mulloy LLEditors: Prisant, L. Michael.Humana Press
• Handbook of Dialysis Therapy. 
  Chapter: Isolated Ultrafiltration 
  White JJ, Mulloy LL, Caruana RJ, Ing TSEditors: Nissenson AR, Fine RN.WB Saunders, PhiladelphiaEdition 4th,
• Join now to see all

Abstracts/Posters

• The difference in prevalence of hypertension in black and white renal transplant patients.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, DiPiro JT, Ethnicity and Disease:10:300
• Superior Renal Allograft Survival with Cyclosporine-Based Immunosuppression: Results of a Double-Blind, Randomized, Prospective Comparison of Neoral and Sandimmune in ...
  Hricik DE for the OLN355 Study Group, Transplantation 67(7): S150, #575
• Mycophenolate Mofetil Effectively Halts the Progression of Chronic Renal Allograft Rejection in Some Patients.
  Mulloy LL, Wynn JJ, Jagadeesan M, Ebrahim MY, Bowley J, Newby BS, Rao RN, Humphries AL, Transplantation 67(9): S602, #240
• Basiliximab (Simulect?) is Safe and Effective in Combination with Neoral?, Steroids, and CellCept? For the Prevention of Acute Rejection Episodes in Renal Transplantat...
  Davies E, Lawen J, Mourad G, Oppenheimer F, Durand D, Gonzalez-Molina M, Mulloy L, Wilkinson A, Girault D, Journal of the American Society of Nephrology 10:725A(A3672)
• Circulating Levels of TIMP-1 in EPO Resistant and Nonresistant Hemodialysis (HD) Patients.
  Lightfoot BO, Fall P, Mulloy LL, Journal of the American Society of Nephrology 1): 290A(A1467)
• Renal Transplant Clinical Patients? Satisfaction with Health Care Quality: Effect of Pharmaceutical Care Services.
  Chisholm MA, Reinhardt BO, Vollenweider LJ, Mulloy LL, Jagadeesan M, Martin BC, Rogers HE, May JR, Wynn JJ, and DiPiro JT, Pharmacotherapy 19(10): 1228
• The Presence of a D Allele in the I/D Polymorphism of Intron 16 of the ACE Gene is not a Predictive Factor for the Development of Nephropathy in Patients with Sickle C...
  Hazariwala S, Kutlar F, Daitch L, Sromek E, Mulloy L, Litaker M, Woods KF, and Kutlar A, Blood 94(10) Suppl 1: #3257, p. 24b
• Impact of Direct Patient Care Clinical Pharmacy Services on Renal Transplant Patient Satisfaction with Health Care Quality.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Wynn JJ, Jagadeesan M, DiPiro JT, Transplantation 69(8): #872, pS338
• Role of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in Post Transplantation Erythropoiesis.
  Lightfoot BO, Ahmed S, Mulloy LL, Jagadeesan M, Transplantation 69(8): #674, pS287
• Renal Transplant Patient Compliance with Free Immunosuppressive Medications.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Wynn JJ, Jagadeesan M, DiPiro JT, Transplantation 69(8): #591: pS264
• Two Year Follow-up of a Randomized, Multicenter Kidney Transplant Study Comparing Tacrolimus (PG) + Azathioprine (AZA) vs. Cyclosporine (neoral) + Mycophenolate Mofeti...
  Gonwa TA, Johnson C, Ahsan N, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M..., Transplantation 69(8): #11, pS113
• Basiliximab (Simulect) is Safe and Effective in Combination with Triple Therapy of Neoral, Steroids and Cellcept in Renal Transplant Recipients.
  Lawen J, Davies E, Mourad G, Oppenheimer F, Gonzalez-Molina M, Bourbigot B, Durand D, Mulloy L, Wilkinson A, Girault D, Transplantation 69(8): #572, p260
• Effect of angiotensin-converting enzyme inhibitor therapy on platelet TIMP-1 production in renal allograft recipients. Possible impact on erythropoiesis.
  Lightfoot BO, Ahmed S, Mulloy LL, Jagadeesan M, Journal of the American Society of Nephrology: 11:722A
• The influence of pharmaceutical care services on the blood pressure of renal transplant patients.
  Chisholm MA, Vollenweider LJ, Martin BC, Mulloy LL, Jagadeesan M, DiPiro JT, Value in Health:3(2): 142
• Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, DiPiro JT, Ethnicity and Disease:10:296
• Comparative Trial of Prograf (Tacrolimus) in Combination with Azathioprine or Mycophenolate Mofetil vs. Neoral (cyclosporine) with Mycophenolate Mofetil After Kidney T...
  Gonwa T for Johnson C, Ahsan N, Halloran P, Stegall M, Hardy M, Metzger R, Shield C III, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, W..., Transplantation 67(7): S239, #930
• Pharmaceutical care services reduce the cost of medications prescribed in renal transplant clinic patients.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT, Pharmacotherapy:20(10): 1280
• Renal transplant clinic patients’ satisfaction with health care quality at 1 and 2 years post-implementation of pharmaceutical care services.
  Vollenweider LJ, DiPiro JT, Mulloy LL, Jagadeesan M, Chisholm MA, Pharmacotherapy: 20(10): 1280
• Pharmaceutical care services reduce adverse drug reactions in renal transplant patients.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT, Pharmacotherapy:20(10): 1270
• Pharmaceutical care services impact on health care cost of renal transplant clinic patients.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Martin BC, Beauchamp K, DiPiro JT, Pharmacotherapy: 20 (10) 1282
• AceI-Induced Attenuation of Platelet Timp-1 Production in Renal Allograph Recipients. Possible Impact on Erythropoiesis.
  Lightfoot BO, Mulloy LL, Jagadeesan M, Ahmed S and Balachandran S, The 2nd International Congress on Immunosuppression Scientific Program and Abstracts 146
• The Amgen Registry of Patients with Chronic Kidney Disease.
  McKeever MO, Doshi MI, Wesson JM, Pereira BJG, Port FK, for the Lewin Group, Journal of the American Society of Nephrology:12:228A
• Randomized Trial of Prograf + Mycophenolate Mofetil or Zaathioprine vs. Neoral + Mycophenolate Mofetil After Cadaveric Kidney Transplantation: Results at Two Years.
  Alfrey EJ, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Corwin C, Danobich G, Wachs M, Veldhui..., The 2nd International Congress on Immunosuppression Scientific Program and Abstracts 127
• Prograf as Secondary Intervention vs Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure.
  Waid T, Holman M, Mulloy L, for the CRAF Study Group, The 2nd International Congress on Immunosuppression Scientific Program and Abstracts 68
• Impacts of direct patient care clinical pharmacy services on renal transplantation patient’s compliance with immunosuppressive therapy.
  Chisholm MA, Vollenweider LJ, Mulloy LL, Jagadeesan M, DiPiro JT, Transplantation 1:306
• Join now to see all

Lectures

• Laboratory Testing in Renal Disease. 
  Georgia Osteopathic Medical Association, 105th Annual Convention & Scientific Exhibition
• Diagnosis and Treatment of Rejection: Chronic and Acute. 
  Multiple locations, 2006
• Renal Transplantation. 
  Dermatology Lecture, Medical College of Georgia
• Update on Hypertension. 
  Anderson County Medical Society (ACMS), Anderson, South Carolina
• Steroid Withdrawal Protocols in Transplant. 
  National Kidney Foundation of Georgia & the Georgia-South, Carolina Society of Nephrology
• Aggressive Strategies for lowering Blood Pressure in At-Risk Patients. 
  Novartis, Summerville, South Carolina
• Getting Kidney Transplantation Closer to Your Patients. 
  Southern Stars Centaurs (Region 4), Regional Social Workers Meeting
• Updates in Transplant Medicine. 
  Medicine Grand Rounds, Medical College of Georgia
• Case Management in Primary Care: A Board Review. 
  Medical College of Georgia, Brasstown Valley Resort, Young Harris, Georgia
• Primary Care Strategies to Reduce the Risk of Kidney Disease. 
  Medical College of Georgia, Brasstown Valley Resort, Young Harris, Georgia
• An Update on the Use of Combination Antihypertensive Therapy in the Prevention of Target-Organ Disease. 
  Pri-Med Updates 2006
• Evaluation of Hematuria & Proteinuria, Part I. 
  Internal Medicine Resident Lecture, Medical College of Georgia
• Evaluation of Hematuria & Proteinuria, Part II. 
  Internal Medicine Resident Lecture, Medical College of Georgia
• Bone Disease in Transplant. 
  The James B. Hudson Annual Nephrology Update, National Kidney Foundation of Georgia
• Recruitment, Challenges, and Best Practices in the IM103027 and IM103008. 
  Bristol-Meyers Squibb IM103-00277 & IM103-008 Regional Meeting
• Pregnancy and the Kidney. 
  Renal Grand Rounds, Medical College of Georgia, Augusta, Georgia
• Evaluation of the Febrile Transplant Patient. 
  Emergency Medicine Lecture, Medical College of Georgia
• Strategies for Treating Hypertension. 
  Georgia Osteopathic Medical Association, 105th Annual Convention & Scientific Exhibition
• Renal Tough-Case Conference. 
  Medical College of Georgia, Kiawah Island, South Carolina
• What’s the ‘Hype’ about Hypertension? 
  Medical College of Georgia, Kiawah Island, South Carolina
• Hematuria and Proteinuria. 
  Physicians Assistant Department Series Lectures, Medical College of Georgia, Augusta Georgia
• Presented Transplant Workshop Cases. 
  The Georgia-South Carolina Society of Nephrology Annual Meeting Update 2007
• Living Donor Evaluation. 
  Internal Medicine Grand Rounds, Medical College of Georgia, Augusta, Georgia
• Transplant Panel Cases and Protocols. 
  The James B. Hudson Annual Nephrology Update, National Kidney Foundation of Georgia, Augusta GA
• Evaluation of Hematuria & Proteinuria. 
  Medical College of Georgia, Physician Assistant Lectures, Augusta Georgia
• Join now to see all

Other

• The Home Show. 
  Mulloy L, Telemedicine
• Kidney Stones. 
  Mulloy L, Health watch, News Channel 26
• How Much Water Should We Drink? 
  Mulloy L, Health watch, News Channel 26
• Transplant Education Instructional Videotapes I-III. 
  Mulloy L
• Problems with Kidneys, Urine and Bladder Control. 
  Mulloy L, Augusta Chronicle Physicians’ Hotline
• Hypertension and Chronic Kidney Disease in the African American Population. 
  Mulloy L, WKZY
• Telemedicine. 
  Mulloy L, New York Times interview
• Transplant Grant funding. 
  Mulloy L, Augusta Chronicle interview
• Renal Transplant. 
  Mulloy L, Pharmacy Practice News interview
• Join now to see all